Kinetic and biologic properties of recombinant ChIFN-γ expressed via CELO-virus vector

Journal of Interferon and Cytokine Research

Volumn 27, Issue 2, 2007, Pages 111-118

  Rauw, Fabienne ^a   Lambrecht, Bénédicte ^a   François, Achille ^b   Langlois, Patrick ^c   Van Den Berg, Thierry ^a  

^a VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^b INSERM   (France)

^c Healthy Pigs Production and Experimentation Section   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; RECOMBINANT CYTOKINE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CHICK EMBRYO LETHAL ORPHAN VIRUS; CHICKEN; CONTROLLED STUDY; DNA REPLICATION; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CHICK EMBRYO; FOWL ADENOVIRUS A; GENE EXPRESSION; INTERFERON TYPE II; KINETICS; RECOMBINANT PROTEINS;

ADENOVIRIDAE; CYTOMEGALOVIRUS; FOWL ADENOVIRUS 1;

EID: 33847101075     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.0097     Document Type: Article

References (43)

1. Digby MR, Lowenthal JW. Cloning and expression of the chicken IFN-γ gene. J. Interferon Cytokine Res. 1995;15:939-945.
2. Lowenthal JW, Digby MR, York JJ. Production of IFN-γ by T chicken cells. J Interferon Cytokine Res. 1995;15:933-938.
3. Ealick SE, Cook WJ, Vijay-Kumar S, Carson M, Nagabhushan TL, Trotta PL, Bugg CE. Three-dimensional structure of recombinant human interferon-gamma. Science 1991;252:698-702.
4. Song KD, Lillehoj HS, Choi KD, Zarlenga D, Han JY. Expression and functional characterization of recombinant chicken interferon-gamma. Vet. Immunol. Immunopathol. 1997;58,321-333.
5. Lowenthal JW, York JJ, O'Neil TE, Rhodes S, Prowse SJ, Strom DG, Digby MR. In vivo effects of chicken IFN-γ during infection with Eimeria. J. Interferon Cytokine Res. 1997;17:551-558.
6. Lowenthal JW, O'Neil TE, Broadway M, Strom AD, Digby MR, Andrew M, York JJ. Coadministration of IFN-γ enhances antibody responses in chickens. J. Interferon Cytokine Res. 1998;18:617-622.
7. Lillehoj HS, Choi KD. Recombinant chicken interferon-gamma-mediated inhibition of Eimeria tenella development in vitro and reduction of oocyst production and body weight loss following Eimeria acervulina challenge infection. Avian Dis. 1998;42:307-314.
8. Johnson MA, Pooley C, Lowenthal JW. Delivery of avian cytokines by adenovirus vectors. Dev. Comp. Immunol. 2000;24:343-354.
9. Rautenschlein S, Sharma JM, Winslow BJ, McMillen J, Junker D, Cochran M. Embryo vaccination of turkeys against Newcastle disease infection with recombinant fowlpox virus constructs containing interferons as adjuvants. Vaccine 2000;18:426-433.
10. Schijns VECJ, Weining KC, Nuijten P, Rijke EO, Staeheli P. Immunoadjuvant activities of E.coli- and plasmid-expressed recombinant chicken IFN-α/β, IFN-γ and IL-1β in 1-day- and 3-week-old chickens. Vaccine 2000;18:2147-2154.
11. Min W, Lillehoj HS, Burnside J, Weining KC, Staeheli P, Zhu JJ. Adjuvant effects of IL-1β, IL-2, IL-8, IL-15, IFN-α, IFN-γ, TGF-β4 and lymphoctatin on DNA vaccination against Eimeria ecervulina. Vaccine 2002;20:267-274.
12. Takehara K, Kobayashi K, Ruttanapumma R, Kamikawa M, Nagata T, Yokomizo, Nakamura M. Adjuvant effect of chicken interferon-γ for inactivated Salmonella enteritidis antigen. J. Vet. Med. Sci. 2003;65:1337-1341.
13. Rosenthal KL, Copeland KFT, Gallichan WS. Recombinant adenoviruses as vectors for mucosal immunity. In: Kiyono H, Ogra PL, McGhee JR, eds. Mucosal Vaccines. San Diego: Academic Press. 1996:147-158.
14. Babiuk LA, Tikoo SK. Adenovirus as vectors for delivering vaccines to mucosal surfaces. J. Biotechnol. 2000;83:105-113.
15. Russell WC. Update on adenovirus and its vectors. J. Gen. Virol. 2000;81:2573-2604.
16. Sheppard M, Werner W, Tsatas E, McCoy R, Prowse S, Johnson M. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Arch. Virol. 1998;143:915-930.
17. Johnson MA, Pooley C, Ignjatovic J, Tyack SG. A recombinant fowl adenovirus expressing the S1 gene of infectious bronchitis virus protects against challenge with infectious bronchitis virus. Vaccine 2003;21:2730-2736.
18. Chiocca S, Kurzbauer R, Schaffner G, Baker A, Mautner V, Cotton M. The complete DNA sequence and genomic organization of the avian adenovirus CELO. J. Virol. 1996;70:2939-2949.
19. Payet V, Arnould C, Picault J-P, Jestin A, Langlois P. Transcriptional organization of the avian adenovirus CELO. J. Virol. 1998;72:9278-9285.
20. Laver WG, Younghusband HB, Wrigley NG. Purification and properties of chick embryo lethal orphan virus (an avian adenovirus). Virology 1971;45:598-614.
21. Potter CW, Oxford JS, Downie JC, Atwood MM, Hardy RD. Chick lethal orphan (CELO) virus: some physical and immunological properties. Virology 1971;44:418-424.
22. Cowen B, Calnek BW, Menendez NA, Ball RF. Chicken adenoviruses: effect on egg production, shell quality and feed consumption. Avian Dis. 1978;22:459-470.
23. François A, Chevalier C, Delmas B, Eterradossi N, Toquin D, Rivallan G, Langlois P. Avian adenovirus CELO recombinants expressing vp2 of infectious bursal disease virus induce protection against bursal disease in chickens. Vaccine 2004;22:2351-2360.
24. Cherenova LV, Logunov DY, Shashkova EV, Shmarov MM, Verkhovskaya LV, Neugodova GL, Kazansky DB, Doronin KK, Naroditsky BS. Recombinant avian adenovirus CELO expressing the human interleukin-2: characterization in vitro, in ovo and in vivo. Virus Res. 2004;100:257-261.
25. François A, Eterradossi N, Delmas B, Payet V, Langlois P. Construction of avian adenovirus CELO recombinants in cosmids. J. Virol. 2001;75:5288-5301.
26. Lambrecht B, Gonze M, Morales D, Meulemans G, van den Berg T. Comparison of biological activities of natural and recombinant chicken interferon-gamma. Vet. Immunol. Immunopathol. 1999;70:257-267.
27. Lambrecht B, Gonze M, Meulemans G, van den Berg T. Production of antibodies against chicken interferon-γ: demonstration of neutralizing activity and development of a quantitative ELISA. Vet. Immunol. Immunopathol. 2000;74:137-144.
28. Lambrecht B, Gonze M, Meulemans G, van den Berg T. Assessment of the cell-mediated immune response in chickens by detection of chicken interferon-gamma in response to mitogen and recall Newcastle disease viral antigen stimulation. Avian Pathol. 2004;33:343-350.
29. Green LC, Waguer DA, Golowski J, Wishnook JS, Tannenbaun SR. Analysis of nitrate, nitrite and (15N) nitrite in biological fluids. Anal. Biochem. 1982;126:131-138.
30. Weining KC, Schultz U, Münster U, Kaspers B, Staeheli P. Biological properties of recombinant chicken interferon-γ. Eur. J. Immunol. 1996;26:2440-2447.
31. Wang J, Michalak TI. Comparison of biological activity of recombinant woodchuck interferon-gamma and tumor necrosis factor alpha produced in baculovirus and Escherichia coli expression systems. Cytokine 2005;30:22-34.
32. Jenkins N, Parekh RB, James DC. Getting the glycosylation right: Implications for the biotechnology industry. Nat. Biotechnol. 1996;14:975-981.
33. Altmann F, Staudacher E, Wilson IBH, Marz L. Insect cells as hosts for expression of recombinant glycoproteins. Glycoconjugate J. 1999;16:109-123.
34. James DC, Freedmann RB, Hoare M, Ogonah OW, Rooney BC, Larionov OA, Dobrovolsky VN, Lagutin OV, Jenkins N. N-Glycosylation of recombinant human interferon-gamma produced in different animal expression system. Biotechnology 1995;13:592-596.
35. Hooker AD, Green NH, Braines AJ, Bull AT, Jenkins N, Strange PG, James DC. Constraints on the transport and glycosylation of recombinant IFN-γ in Chinese hamster ovary and insect cells. Biotechnol. Bioeng. 1999;5:559-572.
36. Stoeckle MY, Falck-Pederson E, Rubin BY, Anderson SL, Murray HW. Delivery of human IFN-γ via gene transfer in vitro: prolonged expression and induction of macrophage antimicrobial activity. J. Interferon Cytokine Res. 1996;16:1015-1019.
37. West CM. Current ideas on the significance of protein glycosylation. Mol. Cell. Biochem. 1986;72:3-20.
38. Schmidt M, Hoffman DR. Expression systems for production of recombinant allergens. Int. Arch. Allergy Immunol. 2002;128:264-270.
39. Cai G, Salonikidis PS, Schwarz W, Schulein R, Reutter W, Fan H. The role of N-glycosylation in the stability, trafficking and GABA-uptake of GABA-transporter 1. Terminal N-glycans facilitate efficient GABA-uptake activity of the GABA transporter. FEBS J. 2005;272:1625-1638.
40. Jafari-Aghadam J, Khajeh K, Ranjbar B, Nemat-Gorgani M. Deglycosylation of glucoamylase from Aspergillus niger: effects on structure, activity and stability. Biochim. Biophys. Acta 2005;1750:61-68.
41. Saraneva T, Pirhonen J, Cantell K, Kalkkinen N, Julkunen L. Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-γ. Biochem. J. 1994;303:831-840.
42. Kelker HC, Yip YK, Anderson P, Vilcek J. Effects of glycosidase treatment on the physicochemical properties and biological activity of human interferon-gamma. J. Biol. Chem. 1983;258:8010-8013.
43. Hooker AD, James D. The glycosylation heterogeneity of recombinant human IFN-γ. J. Interferon Cytokine Res. 1998;18:287-295.